Investors are ignoring EverQuote's limited growth expectations, paying for exposure despite the risk. The predicted future revenues may not support a positive sentiment for long, placing investments at risk.
Insider sale below current stock price suggests they see this as a fair value, a potential negative signal. Ownership shows alignment between management and small shareholders, but past sales warn caution before buying.
B Riley Securities has upgraded EVER and QNST to Buy from Neutral, based on optimism about auto insurance recovery and EverQuote's cost-cutting measures, and decision to focus on core competency by leaving health insurance.
Gainers: •$ビーライト・バイオ(BLTE.US)$+17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1) •$アトコア(ATKR.US)$+12.11% (earnings reports) •$AST スペースモバイル(ASTS.US)$+9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing) •$ハーモニック(HLIT.US)$+7.56% (earnings reports) •$ケマーズ(CC.US)$+7.2% ...
Upgrades •$アゴラ(API.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50 •$アルジェンX(ARGX.US)$: Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278) •$アイダコープ(IDA.US)$: Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108) •$ジャックス パシフィック(JAKK.US)$: BMO Capital Upgrades to Outperform from Market Perform - PT $21 •$コカ・コーラ・フェムサ(KOF.US)$: Barclays Upgrades to Overweight from Equal Wei...
$ロク(ROKU.US)$Keybanc cut Roku, Inc. ROKU price target from $490 to $460 $エバークォート A(EVER.US)$JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17 $トライテラス(TRIT.US)$B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
エバークォート Aに関するコメント
• $ビーライト・バイオ(BLTE.US)$ +17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
• $アトコア(ATKR.US)$ +12.11% (earnings reports)
• $AST スペースモバイル(ASTS.US)$ +9.30% (receives experimental license from FCC for BlueWalker 3 satellite testing)
• $ハーモニック(HLIT.US)$ +7.56% (earnings reports)
• $ケマーズ(CC.US)$ +7.2% ...
• $アゴラ(API.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $12.50
• $アルジェンX(ARGX.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $375 (from $278)
• $アイダコープ(IDA.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $110 (from $108)
• $ジャックス パシフィック(JAKK.US)$ : BMO Capital Upgrades to Outperform from Market Perform - PT $21
• $コカ・コーラ・フェムサ(KOF.US)$ : Barclays Upgrades to Overweight from Equal Wei...
$エバークォート A(EVER.US)$ JP Morgan reduced EverQuote, Inc. EVER price target from $41 to $17
$トライテラス(TRIT.US)$ B. Riley Securities cut the price target on Triterras, Inc. TRIT from $9 to $5
まだコメントはありません